I. Introduction
We scarcely realize that we are alive because inside our body there is a constant, highly vigilant microscopic mechanism designed to defend us every moment from millions of bacteria, microbes, viruses, fungi, parasites and pollutions. This amazing protection mechanism is called the immune system. It is indeed extremely efficient machinery that consists of a highly complex network involving billions of immune components and their interactions and chemical reactions.
However efficient it is, depending on the type of perturbation, it often falls short that leads to a disease condition 1 . As a result we require external treatment to cure the disease. Hence it is rather important to diagnose what is the disease condition and what could be the suitable marker/s for in the diagnostic treatment.
Despite its importance, our understanding of human immune response has remained rather rudimentary. While there do exist clinical observations and systematic experimental studies that can help us identifying some of the essential immune ingredients and their functions [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , we often fail to quantify immune responses because we lack specification of sensitive order parameters that can characterize state of immunity and foretell the onset of disease. Instead, the standard practice is to look for the average values of a number of immune components and opt
for their values in the standard range as signatures of healthy system. Often serious malfunction of the immune system develops over a period of time when average values remain within the range prescribed and may thus fail to give any indication of the impending crisis. Even more concerning is the fact that we take note only when the parameters have already entered the disease condition.
Additionally, one should remember that our immune response is not only highly case (that is, disease) specific but is also personalized. It not only depends on external factors like pathogenic strength, pollution, etc. but also on internal individual immune tolerance [14] [15] [16] .
Therefore, we need to quantify immune response in terms of a suitable order parameter so that clinical diagnosis can more sensitively probe and foretell a disease condition. Before characterizing an appropriate marker we need to know some essential information in the regulation of immune response.
To overcome the onslaught of innumerable types of ever-evolving pathogens, some immune cells having unlimited repertoire of receptors ensure that the invading pathogens are recognized [17] [18] [19] [20] . After the antigen-specific recognition by receptors on lymphocytes, the clonal expansion of pathogen-specific lymphocytes (in brief, specific effector T-cells), directly or indirectly clear the pathogen load. Since the receptors are generated in a random process, these effector immune cells often fail to distinguish self from non-self. As a result, it leads to a serious threat to health which is the development of autoimmunity [20] [21] [22] [23] . A crucial prerequisite is the elimination of such self-reactive receptors by the mechanism of self-tolerance [14] [15] [16] .
Although both genetic and environmental factors affect disease prevalence, autoimmunity is primarily driven by the enhanced population of Th1 helper cells that attack various self-tissues in the body 24, 25 . A number of other effector T cell subsets, like Th17 and Th9 cells, and regulatory T cells, like Tregs and Tr1 cells, also strongly participate in autoimmunity at cellular and molecular levels. Although IL-17 producing Th17 cells are believed to serve as one of efficient players in autoimmunity, the intricate balance between T Reg s and Th17 cells, provide a basis for understanding the immunological mechanisms that induce and regulate autoimmunity 20 . While effector T cells control inflammation, regulatory T cells play a vital role to control it. Physicians usually treat autoimmune diseases with an immunosuppressive drug that decreases the activity of the effector T-cells so that it does not harm body's own tissues or transplanted organs or tissues.
Like corticosteroid medications, vitamin-D is also being exploited as an excellent immune modulator for the prevention of autoimmune disorders 26, 27 .
Overactive immune-suppression often may edit the immune response in such a way that malignant cells may find it relatively easier to evade the immune system [28] [29] [30] . This immuneevasion has been identified as a hall-mark on the onset of at least some types of cancer. Several reports documented that the progression of cancer is involved with an enhanced activity of regulatory T-cells and decreasing effects of effector T-cells [31] [32] [33] [34] [35] [36] [37] [38] . This enhanced activity of regulatory T-cells in presence of excess level of vitamin-D causes significant annihilation of effector T-cell population. Thus the opposing role of regulatory and effector T-cells in immunological activity often determine the strength of immune-regulation and the fate of a disease 20 . The regulation is largely determined by the activation of APCs followed by the production of effector T-cells [39] [40] [41] [42] [43] .
Based on such T-cell response, we have categorized the regulation into three groups: (i) strong regulation, where the population of effector T-cell is less in comparison to the population of regulatory T-cell; (ii) weak regulation, where effector T-cells are larger in population than the regulatory T-cells; and (iii) moderate regulation where both effector and regulatory T-cells maintain a balanced population 44, 45 . We show below that the balance is maintained by a bistability.
In our earlier study we developed a coarse grained but general kinetic model in an attempt to capture the role of vitamin-D in immunomodulatory responses 44 . We found that although vitamin-D plays a negligible role in the initial immune response, it exerts a profound influence in the long term, especially in helping the system to achieve a new, stable steady state.
The study explores the role of vitamin-D in preserving an observed bistability in the phase diagram (spanned by system parameters) of immune regulation, thus allowing the response to tolerate a wide range of pathogenic stimulation which could help in resisting autoimmune diseases 44 . 
II.Theoretical description of immune response

A. Definition of immune response in terms of fluctuations
A response function provides a quantitative measure of the response of a system to external perturbation 48, 49 . In equilibrium statistical mechanics, such response functions are defined in terms of mean square fluctuations in the conjugate system properties [50] [51] [52] 
Here we assume T cell concentration is a function of i and j where i represents an individual and j represents a disease.
We note that our system is not an equilibrium system. However, the system does attain a steady state, even in the presence of pathogenic load.
B. Source of fluctuations
Let us consider a small volume element in our body, either in a blood sample or in a tissue. We consider that in that volume element there is initially only one pathogen and a certain number of native T-cells that on appropriate signal reception can convert into effector or regulatory T-cells. We also assume a fixed number of antigen presenting cells (APC) that in the presence of pathogen activates native T-cell. All these response functions we desire to calculate from a stable kinetic network model of T-cell regulation that we developed in our early work 44 .
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D. Quantification of immune response function (IMRF) : Connecting series of events
The important constituents of the model are the following: (i) pathogen (it is important to note that, in our analyses we have considered pathogen, as a numerical quantity "P" that is It is important to emphasize here that we have essentially combined three important experimental observations those include the essential features of the adaptive responses reported by (i) Powri and Maloy, 42 (ii) Jorge Correale et al. 37 and (iii) Lorenzo Piemonti et al. 43 . In Figure 1 we have presented the complex interaction network model that comprises various components and their inter-relation and regulation involved in the immune system. The present approach of network kinetic model building bears strong resemblance to similar methods adopted earlier in the study of kinetic proof reading 55, 56 and also in enzyme kinetics [57] [58] [59] . In all these studies, precise quantitative prediction is hindered by insufficient knowledge about the system parameters. Especially, the values of rate constants are often not available. This lacuna is indeed a source of serious problem not only in study of kinetic proof reading and enzyme kinetics but also, as we find here, in any theoretical investigation of Coarse-graining of the interaction network is accomplished by making several simplifying assumptions. They are as follows:
(a) Th1, Th2 and Th17 cells are grouped together as effector T-cells. The detailed description of these T-cells is depicted in our previous work 44 . That is, we assume that they act together, in a parallel fashion. In the present analysis we consider the following set of connected biological reactions.
Most of them are catalytic reaction in terms of up-regulation or down-regulation.
(1) The primary step is the annihilation of pathogen by effector T-cell.
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Pathogen P +Effector T-cell T P + T → We now transform the above set of connected biochemical transformations into rate equations. They give rise to a chemical network.
B. Master equations quantifying the reaction network dynamics
Now, we make a few important assumptions before we set about writing the master equations.
(i) Pathogen, inactive APC and naive T-cells, each has a birth rate which includes influx and proliferation rates and a death rate similar to decay which incorporates natural cell death. The death rate of each component is linear in its concentration.
(ii) The transition probabilities are all assumed to be constant with time but may vary from system to system (i.e. here person to person) according to the condition applied.
(iii) To scale the unit, here we assume that in absence of pathogen, hundred (average number of T-cells present in hundred nano-liter blood sample) precursor T-cells pre-exist in our volume element.
The annihilation, recombination and catalytic reactions articulated above lead to the following set of coupled master equations. The equations are size-extensive. Size extensibility is an important element of our model. 
where the respective terms denote the following quantities : 
C. System parameters and data analysis
A set of nine coupled differential equations is difficult to solve analytically. We obtain the time dependent concentrations of all the components involved in the scheme by employing the well-known stochastic simulation analysis proposed by Gillespie 62 . Both the single molecular as well as ensemble enzyme catalysis have been studied following this method. All the results presented in this article are derived using stochastic simulation method. However, we have also verified the consistency of each result by using the direct deterministic approach which is easier to implement.
As already mentioned, here we have considered one hundred nano-litre volume of blood sample.
In the absence of pathogen this blood sample effectively contains the steady state concentration of all the precursor cells [68] [69] [70] . Since all the reactions are bimolecular, the volume dependence of the reaction is expected to be an issue. Thus, we have kept fixed the box volume to one hundred nano-liter and all the rate constants are in the unit of per day.
Furthermore, we have assumed that in the absence of antigen, hundred precursor T-cells can pre- In addition, the concentration of precursor elements was normalized, so as to reflect manifold change in the production level. Taking typical values as mentioned below (see Table 1 ), the time evaluation of the system and other analyses are performed in the present work. Here we have used the standard definition of steady state, i.e.; when the concentration of different species is invariant with time (dc/dt=0). In particular, for stochastic simulation, a steady state is assumed to reach when the concentration of a species fluctuates around a mean value without any noticeable drift at long time. 
A. Immune response via T-cell fluctuations
A healthy immune system usually functions with a balanced regulation that maintains the population of effector T-cells at an appropriate level, adequate for the clearance of pathogens.
The production of effector T-cells again depends on the APC activation process, controlled by the rate parameter of APC activation by pathogenic stimulation (k inp ). We have studied all the three regulation limits as mentioned before at different pathogenic stimulation (k inp ). k inp is an important rate parameter in our analysis, and in adaptive immune system.
As discussed earlier, the most stable and safe physiological state is the moderately regulated regime. This state is balanced between the two states, both of which are undesirable. This balance is achieved via a bi-stability which may give rise to large fluctuations that can be harnessed for immune purpose, if and when needed.
There may be experimental evidence on the role of fluctuation in immune response. A recent study conducted with 20 healthy individuals after strenuous physical activity showed significant decrease in the CD4 lymphocyte count after the rest for 60 minutes. The baseline mean CD4+ T cell count in these individuals at 0 min was 1060x10 6 /l which was found to decrease to 660x 10 6 /l after a rest for 60 minutes. Hence concentration of CD4+ T cells has been observed to fluctuate significantly in a healthy system 71 . Thus it is natural to assume that such variation is exploited in the immune response.
In order to explore the T-cell population fluctuations in the three regulation regime as mentioned earlier, we monitor the quantity, In certain sense, this expression is the analog of the thermodynamic response given by the isothermal compressibility. However, this response is calculated at the steady state condition achieved by a constant, small influx of pathogen.
It is observed that our system of equations display a rather sharp crossover from a strong to weak regulation as the magnitude of pathogenic stimulation (k inp ) increases from a low value (see Figure 2) . This crossover is a sensitive function of many parameters, notably the vitamin D concentration. At the crossing point, we observe a bistability in immune response.
Each peak position in the curves forms the ridge shown in Figure 2 .
Relative fluctuations of Tcells (both for effector and regulatory) exhibit a rapid (divergent-like) growth at a point near the bistable crossover region. From our results it seems that system requires relevant fluctuation at homeostasis.
A recent clinical study has reported that the disease states in cancer patients both T Eff mean frequency and its mean coefficient of variation are rather significantly reduced 71, 72 . However this study did not find any such change in regulatory T-cell subset. Many other case studies show that cancer patients have a significantly higher frequency of regulatory T-cells. This signifies that the system is under strong regulation. In 2012, a pilot study over a number of ovarian cancer patients revealed the increased levels of recently activated regulatory T-cell subsets with tumor migrating ability (CD4+CD25 hi Foxp3+CD127−CCR4+CD38+ cells) in those patients when compared to healthy participants 73 . Such enhanced level of regulatory T-cells are largely found to be reluctant to being "re-set" to healthy control homeostatic levels even after the chemotherapeutic perturbation.
In that relation, Figure 2 shows that not only under strong regulation limit, effector and regulatory T-cell fluctuations decrease at any disease state, whether it is cancer prone or autoimmune. We believe that due to the dearth of necessary fluctuations (especially under the strong regulation limit), regulatory T-cell frequency becomes highly resistant to being "re-set" to their normal homeostatic level in cancer patients, as indeed been observed in some cases.
The present study suggests that not only the absolute values of the effector and regulatory T-cell populations are important, but their fluctuations are also important and independent measure of immune response system.
Our results also clearly demonstrate that for such complex in vivo systems, the occurrence of instabilities and non-equilibrium phase transition phenomena cannot be reliably understood from a complete deterministic approach as such description completely ignores system's inherent More importantly, the system may use these fluctuations in immune response by undergoing phase transition into the other regulation phase. Nevertheless, it is important to note that except some very sensitive order parameter, such isolated fluctuation is rather difficult to arrest in a number of order parameter profiles. Moreover, the result emphasizes the scope of diagnosis of a disease in a patient specific manner. 
C. Bistablity and co-existence of steady state branches
In the light of our previous results, it is worth mentioning here that fluctuations are always present in cellular systems due to the stochastic nature of the elementary processes 48 .
These fluctuations exert more profound effect and can induce new activities in small scale systems which may not be predicted or captured by any mean-field description or macroscopic rate laws. While noise, whether external or internal can cause a finite system to fluctuate between two stable states in bistable systems, macroscopic rate laws predict an asymptotic behavior that ignores such oscillations. Hence we need to understand the concept of bistability in the fluctuating environment as it is a basic phenomena of cellular functioning. In our model bistability is augmented in the system due the inhibitory effect of regulatory T cells on the activation of APC and effector T-cells. Furthermore, this augmentation is dependent on the level of vitamin-D. Interestingly, in the bistability condition system becomes more robust to tolerate significant changes of pathogenic stimulation. Here one typically finds strongly broadened probability distribution with a clear bimodal nature that is seen only in the vicinity of bistable point.
As mentioned, we find the occurrence of bistability in the moderate (that is, healthy) regulation regime through the coexistence of two stable steady states as shown in Figure 4 . When such a system enters the bistable state with roughly equal levels of key determinants (in our case effector and regulatory T-cell populations), effects of stochastic fluctuation become amplified. It also depends on the external rate parameters which may enforce a final selection. As a result of these fluctuations, such complex biological systems may undergo modifications of their steady state properties. In particular, when the variance of fluctuations increases around a well defined mean value, transient phenomena appear which may absent in a typical bifurcation diagrams.
Hence the properties of the non-fluctuating systems may not be considered as a first approximation to the properties of the real system 48 . 
E. Relaxation behavior in healthy and disease states
By using the universality observed in critical phenomena it may be possible to provide quantitative predictions for the immunological condition of a given person by following the relaxation behavior 78, 79 . In the present case one can however perform a perturbation (pulse) experiment in situations where the immune system is (i) far from a transition (strong regulation and weak regulation) and (ii) in the case when the state is close to a transition (near bistable region). Such an "experiment" could clearly reveal the difference in time evolution leading to relaxation to its initial equilibrium state. The longer that time the system would take, the less stable is the system and thus we can assure that it is more close to a potential tipping point.
In Figure 6 
V. Conclusion
In the present work we have attempted to provide a quantitative definition of personalized immune response of an individual human being to a given specific pathogen. We propose that personalized immune response can be quantified by an appropriate response function. Ideally, one should be able to categorize and quantify specific immune response so that appropriate preventive measures can be taken. The application of linear response theory, in this aspect, might be useful in the diagnosis of different stages of a disease in addition to the measurements of ratios or standardization of the concentrations of some potent cells or protein levels currently being advocated 72, 80, 81 .
We have followed methods of statistical mechanics in defining such individual-specific immune 
